Amarin Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMARIN PHARMS, and when can generic versions of AMARIN PHARMS drugs launch?
AMARIN PHARMS has two approved drugs.
There are seventy US patents protecting AMARIN PHARMS drugs.
There are three hundred and thirteen patent family members on AMARIN PHARMS drugs in forty-six countries and twenty supplementary protection certificates in thirteen countries.
Drugs and US Patents for Amarin Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | AB | RX | Yes | Yes | 8,399,446 | ⤷ Sign Up | ⤷ Sign Up | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | AB | RX | Yes | Yes | 8,703,185 | ⤷ Sign Up | ⤷ Sign Up | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | AB | RX | Yes | Yes | 11,000,499 | ⤷ Sign Up | ⤷ Sign Up | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | AB | RX | Yes | Yes | 10,894,028 | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Amarin Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | 8,188,146 | ⤷ Sign Up |
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | 8,188,146 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for AMARIN PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 1 g | ➤ Subscribe | 2013-01-15 |
➤ Subscribe | Capsules | 500 mg | ➤ Subscribe | 2017-08-29 |
➤ Subscribe | Capsules | 1 g | ➤ Subscribe | 2016-07-26 |
International Patents for Amarin Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 108096237 | ⤷ Sign Up |
New Zealand | 743714 | ⤷ Sign Up |
Canada | 2759284 | ⤷ Sign Up |
Japan | 2013075926 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Amarin Pharms Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2443246 | PA2021522 | Lithuania | ⤷ Sign Up | PRODUCT NAME: IKOZAPENTO ETILAS; REGISTRATION NO/DATE: EU/1/20/1524 20210326 |
2443246 | 39/2021 | Austria | ⤷ Sign Up | PRODUCT NAME: ICOSAPENT-ETHYL (= EICOSAPENTAENSAEUREETHYLESTER,; REGISTRATION NO/DATE: EU/1/20/1524 20210329 |
2443246 | CA 2021 00036 | Denmark | ⤷ Sign Up | PRODUCT NAME: ICOSAPENT ETHYL; REG. NO/DATE: EU/1/20/1524 20210329 |
2443246 | 132021000000156 | Italy | ⤷ Sign Up | PRODUCT NAME: ICOSAPENT ETILE(VAZKEPA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1524, 20210329 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.